The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
June 10, 2025
Quarterly Article
Magdalena Cerdá
DANIEL B. NEILL
ELLICOTT C. MATTHAY
JOHNATHAN A. JENKINS
BRANDON D. L. MARSHALL
Katherine Keyes
December 2024
September 2024
Back to The Milbank Quarterly
Policy Points:
See all articles in the special issue, Mental Health and Substance Use Challenges Facing the United States: What Can State Policymakers Do?
People in the United States are dying at record numbers from overdose.1 Overdose deaths increased from fewer than 17,000 deaths in 1999 to an estimated 100,000 deaths approximately 25 years after, with a peak of almost 108,000 deaths in 2022.2 Racial/ethnic minoritized groups are now particularly affected: in 2023, the highest rates of overdose were among non-Hispanic Black and American Indian/Alaska Native Americans.3 Although overdoses increasingly involve both opioids and stimulants, opioids contribute to over three-quarters of all overdose deaths, primarily driven by illegally manufactured synthetic opioids like fentanyl.1
Provisional data indicate that we have seen an overall decline in US overdose deaths in the past 2 years, with a decline of 4% in 2022–2023 and 17% in 2023–2024.4 Despite this substantial decline, the number of deaths per year remain higher than they were prior to the start of the COVID-19 pandemic. Further, this decline has been unequally experienced across racial and ethnic groups. According to the latest available race-specific data, White populations saw a 7% decline in 2022–2023 compared with a 3% increase among Black Americans, a 39.4% increase among Native Hawaiian or Other Pacific Islander populations, and no change among other racial/ethnic groups.3 These patterns signal a need to develop targeted and tailored interventions that effectively reduce both total overdose deaths and disparities in overdose.
Drug overdose deaths: facts and figures. National Institute on Drug Abuse, National Institutes of Health. August 21, 2024. Accessed July 25, 2023. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-ratesGoogle Scholar
Spencer MR, Garnett MF, Miniño AM. Drug Overdose Deaths in the United States, 2002–2022. NCHS Data Brief No 491. National Center for Health Statistics; 2024.Google Scholar
Garnett MF, Miniño AM. Drug Overdose in the United States, 2003–2023. NCHS Data Brief No 522. National Center for Health Statistics; 2024.Google Scholar
Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. Updated May 14, 2025. Accessed January 1, 2025. https://dx.doi.org/10.15620/cdc/20250305008ViewGoogle Scholar